GenSight Biologics S.A.

€0.07As of Sun 8 Nov 2026, 12:00 UTC
EPA:SIGHTHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (37.75%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.69
PE TTM —
TSR TTM (50.36%)
Mkt cap €16.23M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.0869
25.54%
109.80%
Hold 10|9|8|11|6
4Q25
1Q26
2Q26
3Q26
Earnings per share€
—
—
—
—
8.74%
14.11%
9.97%
25.23%
Revenue€M
1.754
1.796
1.851
1.818
4.31%
9.74%
11.42%
6.96%
Peers (US$18.22M)
Cap (US$)
PE
16.67M
—
15.57M
—
18.21M
38.63x
Capital
TTM
5Y
10Y
Leveragex
1.134
0.807
0.786
EBIT/Intx
1.616
0.496
0.321
Own earn%
3.16
93.21
78.57
Sh yield%
21.77
49.95
49.51
Owners
Insiders/Inst%
9.58
33.19
Short interest%
5.83
SBC / revenue%
0.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
2–5
$1 testx
—
Incr. ROIC%
6